Dr. Supriya Sharma, chief medical adviser at Health Canada, holds a press conference in Ottawa on Friday, Feb. 26, 2021, to provide an update on the COVID-19 pandemic and vaccine rollout in Canada. THE CANADIAN PRESS/Sean Kilpatrick

Dr. Supriya Sharma, chief medical adviser at Health Canada, holds a press conference in Ottawa on Friday, Feb. 26, 2021, to provide an update on the COVID-19 pandemic and vaccine rollout in Canada. THE CANADIAN PRESS/Sean Kilpatrick

Chief medical adviser says Health Canada preparing for quick approval of boosters

There are three variants of concern now identified in Canada

Canada’s chief medical adviser says her department is constantly receiving and reviewing any data on vaccines and COVID-19 variants and will be ready to quickly authorize needed boosters when they’re available.

But Dr. Supriya Sharma said the three vaccines authorized in Canada so far offer excellent protection and, along with public health measures, can help slow the spread of the virus and potentially help stop it from mutating even further.

“We knew this was going to happen, that we would have variants,” she said, in an interview with The Canadian Press.

Coronaviruses don’t mutate as quickly as the flu, but do change as they spread among people and the more they spread, the more they change. To that end, Sharma said the slower the spread, the fewer variants we will see.

“So a virus is not going to mutate as much when it can’t replicate,” she said.

There are three variants of concern now identified in Canada, including B.1.1.7, first identified in the United Kingdom, B. 1.351, identified in South Africa, and P. 1, identified in Brazil.

Canada’s authorized vaccines, Pfizer-BioNTech, Moderna and Oxford-AstraZeneca, all appear to have very good results against B.1.1.7, which is the most common variant so far found in Canada.

Chief Public Health Officer Dr. Theresa Tam said Wednesday 1,324 cases of B.1.1.7, 103 B. 1.351 and 3 of P. 1 have been identified across Canada.

In Israel, where more than half the population has received at least one dose of the Pfizer-BioNTech vaccine, studies have shown significant reductions in the spread of the virus, as well as hospitalizations and deaths. The B.1.1.7 variant is dominant in Israel, making up more than 80 per cent of the cases there now.

The B. 1.351 variant is a bit more concerning for vaccines. South Africa stopped using AstraZeneca altogether after lab tests suggested it wouldn’t be very effective against mild illness for B. 1.351, which is dominant in that country.

That decision has contributed to growing concerns that AstraZeneca’s vaccine is less desirable but Sharma said the details aren’t that simple.

“Now, if you look at severe disease, or more severe cases, it actually looked like it was still quite protective,” she said.

“But in a country where that is your dominant circulating stream, and in a country where they had potentially had access to another vaccine shortly, they made the decision that maybe they weren’t going to go ahead with that,” she said.

If B. 1.351 becomes a dominant strain here, and the vaccines don’t show effectiveness against it, they’ll be pulled, she said.

”We wouldn’t leave a vaccine on the market, if we think that it wouldn’t be effective for the overall population,” she said.

All three vaccine makers have to keep updating Health Canada with any information they have about how their injections are handling new variants.

Most are also already working on boosters to address limitations their original vaccines may have.

When those boosters are ready, Health Canada won’t need very long to review them, said Sharma.

“We’re working with our international regulatory partners, to come together with aligned guidance, to provide to companies to give them some guidance on what type of evidence we would need to see for an updated vaccine,” she said.

Health Canada worked with both the U.S. Food and Drug Administration and the European Medicines Agency to establish similar guidelines for what companies had to do to get their COVID-19 vaccines approved the first time.

Canada’s authorizations were independent but were completed alongside the U.S. and Europe.

Any boosters would be handled in a similar way to how Health Canada manages the flu vaccine each year, which is adjusted annually to account for the changes in flu strains that are dominant.

Smaller-scale clinical trials and lab tests, that can be completed and reviewed much more quickly, are likely.

“They still need to demonstrate that the vaccine that comes out is still safe, effective and high quality,” she said.

READ MORE: Federal panel recommends 4-month gap between COVID vaccine doses due to limited supply

Mia Rabson, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Katherine Swampy
Maskwacis chiefs are opposed to RAPID Response

Alberta Treaty 6 First Nations say they were not properly consulted

UCP Lacombe-Ponoka MLA Ron Orr spoke to the Ponoka Chamber about the potential a new provincial government would provide to help support small business.
File photo
MLA Ron Orr: ‘Our constituents … want us to defend their livelihoods and freedoms’

Lacombe-Ponoka MLA stands with 15 other UCP members calling out retreat on restrictions

Conservative leader Erin O’Toole holds a press conference on Parliament Hill in Ottawa on Tuesday, April 6, 2020. Top Tory leaders of past and present will speak with supporters today about what a conservative economic recovery from COVID-19 could look like. THE CANADIAN PRESS/Sean Kilpatrick
O’Toole to vote against Conservative MP’s private bill on ‘sex-selective abortion’

Erin O’Toole said he supports a woman’s right to choose and will personally vote against the private member’s bill

A health-care worker holds up a vial of the AstraZeneca Covishield vaccine at a COVID-19 vaccination clinic in Montreal, Thursday, March 18, 2021. THE CANADIAN PRESS/Paul Chiasson
PHAC receives first report of blood clot linked to AstraZeneca

The federal agency says the person is now recovering at home

A real estate sign is pictured in Vancouver, B.C. THE CANADIAN PRESS Jonathan Hayward
1 in 3 young Canadians have given up on owning a home: poll

Data released Monday says 36% of adults younger than 40 have given up on home ownership entirely

Ryan Applegarth
Applegarth’s murder charges proceed

Ryan Jake Applegarth, charged with the second degree murder of Chantelle Firingstoney,… Continue reading

Dr. E. Kwok administers a COVID-19 vaccine to a recipient at a vaccination clinic run by Vancouver Coastal Health, in Richmond, B.C., Saturday, April 10, 2021. THE CANADIAN PRESS/Jonathan Hayward
Most Canadians plan to get COVID-19 vaccine, but safety fears drive hesitancy: poll

This comes as confidence in governments is plummeting in provinces being hit hardest by the pandemic

Marathon of Hope runner Terry Fox is shown in a 1981. (THE CANADIAN PRESS/CP)
Terry Fox’s legacy of resilience resonates during COVID-19 crisis, says brother

Fred Fox said his brother’s legacy of resilience has taken on renewed resonance as COVID-19 rages on

Madelyn Boyko poses along with a number of the bath bombs she makes with her mom, Jessica Boyko. Madelyn says she enjoys making the bath bombs with her mom as it is a special time for just the two of them. (Photo Submitted)
5-year-old Sylvan Lake girl selling bath bombs in support of younger brother

Madelyn Boyko is selling bath bombs for CdLS research in honour of her younger brother

A sign on a shop window indicates the store is closed in Ottawa, Monday March 23, 2020. The Canadian Federation of Independent Business is raising its estimate for the number of businesses that are considering the possibility of closing permanently. THE CANADIAN PRESS/Adrian Wyld
Small business struggling amid COVID-19 pandemic looks for aid in Liberals’ budget

President Dan Kelly said it is crucial to maintain programs to help businesses to the other side of the pandemic

The National Security and Intelligence Committee of Parliamentarians says that includes attempts to steal Canadian research on COVID-19 and vaccines, and sow misinformation. (AP Photo/Esteban Felix)
Intelligence committee warns China, Russia targeting Canadian COVID-19 research

Committee also found that the terrorist threat to Canada has shifted since its last such assessment

Most Read